spermidine supplement
Pre-clinical- Indications
- Metabolic disease, Chronic disease, Aging
Company intelligence / Profile preview
Kalin Health is a private health and longevity company developing a spermidine-based nutritional supplement intended to promote autophagy, cellular health, healthspan, and longevity. The company presents itself as pursuing a proactive aging approach and states that its lead product has been evaluated in an early clinical trial. Its intellectual property appears centered on spermidine-supplemented food products designed to increase bioavailable spermidine levels. Kalin Health has also filed the CELLITAS trademark for dietary and nutritional supplements focused on cellular health, autophagy, healthy aging, and longevity. The business appears to operate more like a nutraceutical or consumer health company than a traditional drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kalin Health.